Launched in 2026, Novera is an international open-access journal published by Novera Press that focuses on outstanding contributions to precision medicine. The journal maintains strict policies and procedures for editorial evaluation, peer review, and publication ethics.
Submit Manuscript
This Collection highlights recent advances in cancer metastasis research, from molecular mechanisms to translational strategies for improved patient outcomes.
This Collection focuses on single-cell and spatial transcriptomic technologies to map cellular heterogeneity, tissue context, and disease-driving biology.
This Collection explores AI and multimodal analytics in precision medicine for stratification, biomarker discovery, treatment selection, and outcome prediction.
This Collection centers on GWAS, Mendelian randomization, and cross-trait genomic methods to uncover shared heritability, causal links, and therapeutic targets.
Launched in 2026, Novera is an international open-access journal committed to publishing high-quality research in precision medicine. The journal operates under stringent editorial and peer-review standards, ensuring excellence, transparency, and scientific rigor.
The editorial board comprises distinguished researchers from multiple countries, whose expertise spans a wide range of disciplines in precision medicine. Novera seeks to serve as a global platform for the dissemination of impactful scientific advances.
News & Comment